AnaptysBio, Inc. ANAB Research and development expense
Research and development expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s research and development expense?
- AnaptysBio, Inc. (ANAB) reported research and development expense of $33.99M in Q1 2026.
- How has AnaptysBio, Inc.'s research and development expense changed year-over-year?
- AnaptysBio, Inc.'s research and development expense decreased by 17.5% year-over-year, from $41.18M to $33.99M.
- What is the long-term trend for AnaptysBio, Inc.'s research and development expense?
- Over 3 years (2021 to 2024), AnaptysBio, Inc.'s research and development expense has grown at a 18.5% compound annual growth rate (CAGR), from $98.5M to $163.84M.